Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Anal Canal Carcinoma × Vaccines × Gynecologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1 Gynecologic 1 Gastrointestinal 1

Conditions

Uterine Cervical Neoplasms 12 Uterine Cervical Dysplasia 7 Persistent Infection 5 Papillomavirus Infections 5 Condylomata Acuminata 4 Vulvar Neoplasms 3 Anus Neoplasms 3 Vaginal Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 1 High Grade Cervical Intraepithelial Neoplasia 1 Anal Canal Carcinoma 1

Interventions

pembrolizumab 1 atezolizumab 1 Vaccines 1 Magnetic Resonance Spectroscopy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03946358 2024-12-20

VolATIL

Centre Hospitalier Universitaire de Besancon

Phase 2 Completed

GastrointestinalGynecologicHead & Neck

Anal Canal Carcinoma, Squamous Cell Carcinoma of Head and Neck, Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡